NEWS AND EVENTS

Amazing blog post

News

Third Trademark Issued

(BUFFALO, NY) Apr. 1, 2022—Efferent Labs, Inc., a preclinical-stage biodevice company focused on in vivo cellular data, today announced that the United States Patent and Trademark

Efferent Labs Issued 6th Patent

(BUFFALO, NY) Feb. 15, 2022—Efferent Labs, Inc., a preclinical-stage biodevice company focused on in vivo cellular data, today announced that the United States Patent and Trademark

Study Published in European Heart Journal

Overview Efferent Labs CMO, Dr. Spencer Rosero, was invited to present the findings and efforts of Efferent Labs work in collaboration with Evotec A.G. at

Efferent Wins Lumiate Position

(Rochester, NY) Nov 14, 2018 Efferent Labs,, Inc. is proud to have won a position in the second cohort of Luminate. Empire State Development (ESD)

Events

Efferent Labs at NYBio 2018

FOR IMMEDIATE RELEASE Efferent Labs™ at 2018 NewYorkBIO (BUFFALO, NY) April 24, 2016 – Efferent Labs will present the CytoComm™ BiosensorPlatform at the NYBio Annual

Our transformative technology platform will dramatically reduce R&D costs.